PT88383A - Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet - Google Patents
Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignetInfo
- Publication number
- PT88383A PT88383A PT88383A PT8838388A PT88383A PT 88383 A PT88383 A PT 88383A PT 88383 A PT88383 A PT 88383A PT 8838388 A PT8838388 A PT 8838388A PT 88383 A PT88383 A PT 88383A
- Authority
- PT
- Portugal
- Prior art keywords
- von
- methylpropionsaeure
- chlorbenzamido
- enthaltenden
- geeignet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873729209 DE3729209A1 (de) | 1987-09-01 | 1987-09-01 | Verwendung von bezafibrat zur behandlung von diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
PT88383A true PT88383A (pt) | 1989-07-31 |
PT88383B PT88383B (pt) | 1992-10-30 |
Family
ID=6334986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT88383A PT88383B (pt) | 1987-09-01 | 1988-08-31 | Processo para a preparacao de composicoes farmaceuticas contendo acido 2-<4-{2-(4-clorobenzamido)-etil}-fenoxi>-2-metil-propoionico apropriadas para o tratamento de diabetes |
Country Status (16)
Country | Link |
---|---|
US (1) | US5304575A (pt) |
EP (1) | EP0305890B1 (pt) |
JP (1) | JP2647918B2 (pt) |
KR (1) | KR890004690A (pt) |
AT (1) | ATE95694T1 (pt) |
AU (1) | AU610228B2 (pt) |
CA (1) | CA1323575C (pt) |
DE (2) | DE3729209A1 (pt) |
DK (1) | DK472688A (pt) |
ES (1) | ES2059457T3 (pt) |
HU (1) | HU200687B (pt) |
IE (1) | IE62189B1 (pt) |
IL (1) | IL87566A0 (pt) |
PH (1) | PH24568A (pt) |
PT (1) | PT88383B (pt) |
ZA (1) | ZA886459B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
AU4050797A (en) * | 1996-08-02 | 1998-02-25 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
WO1999005161A1 (en) * | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
WO2001051454A1 (en) * | 2000-01-13 | 2001-07-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US20050148497A1 (en) | 2002-02-20 | 2005-07-07 | Khan Mohammed A. | Method for administering glp-1 molecules |
US7264813B2 (en) * | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
US20060286129A1 (en) * | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
JP4901218B2 (ja) * | 2004-02-09 | 2012-03-21 | あすか製薬株式会社 | 併用医薬 |
FR2898894B1 (fr) * | 2006-03-24 | 2008-06-06 | Genfit Sa | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations |
US10098860B2 (en) * | 2016-07-20 | 2018-10-16 | Cipla Limited | Bezafibrate for the treatment of cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2149070C3 (de) * | 1971-10-01 | 1978-03-23 | Boehringer Mannheim Gmbh, 6800 Mannheim | Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel |
JPS56145261A (en) * | 1980-04-10 | 1981-11-11 | Kaken Pharmaceut Co Ltd | Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient |
-
1987
- 1987-09-01 DE DE19873729209 patent/DE3729209A1/de active Granted
-
1988
- 1988-08-18 IE IE252988A patent/IE62189B1/en not_active IP Right Cessation
- 1988-08-24 DK DK472688A patent/DK472688A/da not_active Application Discontinuation
- 1988-08-25 EP EP88113831A patent/EP0305890B1/de not_active Expired - Lifetime
- 1988-08-25 DE DE88113831T patent/DE3884895D1/de not_active Expired - Fee Related
- 1988-08-25 HU HU884456A patent/HU200687B/hu not_active IP Right Cessation
- 1988-08-25 ES ES88113831T patent/ES2059457T3/es not_active Expired - Lifetime
- 1988-08-25 AT AT88113831T patent/ATE95694T1/de not_active IP Right Cessation
- 1988-08-25 IL IL87566A patent/IL87566A0/xx unknown
- 1988-08-26 AU AU21586/88A patent/AU610228B2/en not_active Ceased
- 1988-08-26 PH PH37464A patent/PH24568A/en unknown
- 1988-08-31 ZA ZA886459A patent/ZA886459B/xx unknown
- 1988-08-31 CA CA000576196A patent/CA1323575C/en not_active Expired - Fee Related
- 1988-08-31 PT PT88383A patent/PT88383B/pt not_active IP Right Cessation
- 1988-09-01 JP JP63216469A patent/JP2647918B2/ja not_active Expired - Lifetime
- 1988-09-01 KR KR1019880011350A patent/KR890004690A/ko not_active Application Discontinuation
-
1992
- 1992-12-17 US US07/993,525 patent/US5304575A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3729209C2 (pt) | 1989-08-03 |
EP0305890B1 (de) | 1993-10-13 |
AU2158688A (en) | 1989-05-25 |
HU200687B (en) | 1990-08-28 |
JPS6471813A (en) | 1989-03-16 |
ES2059457T3 (es) | 1994-11-16 |
IE882529L (en) | 1989-03-01 |
US5304575A (en) | 1994-04-19 |
IE62189B1 (en) | 1994-12-28 |
DE3729209A1 (de) | 1989-03-09 |
DK472688A (da) | 1989-03-02 |
ATE95694T1 (de) | 1993-10-15 |
CA1323575C (en) | 1993-10-26 |
IL87566A0 (en) | 1989-01-31 |
AU610228B2 (en) | 1991-05-16 |
KR890004690A (ko) | 1989-05-09 |
HUT47427A (en) | 1989-03-28 |
ZA886459B (en) | 1989-05-30 |
DE3884895D1 (de) | 1993-11-18 |
PT88383B (pt) | 1992-10-30 |
DK472688D0 (da) | 1988-08-24 |
EP0305890A3 (en) | 1990-08-22 |
PH24568A (en) | 1990-08-03 |
JP2647918B2 (ja) | 1997-08-27 |
EP0305890A2 (de) | 1989-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68911103D1 (de) | Verwendung von Fettsäuren zur Behandlung von myalgischer Enzephalomyelitis. | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
PT88383A (pt) | Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet | |
DE69106586D1 (de) | Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris. | |
DE69010162D1 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
DE3878627D1 (de) | Zusammensetzung zur oberflaechenbehandlung von kautschuk. | |
DE69126646D1 (de) | Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure | |
DE3785132D1 (de) | Herstellung optisch aktiver cyclopropancarbonsaeuren. | |
ATE174221T1 (de) | Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten | |
ATE137116T1 (de) | Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen | |
DE68904462D1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten. | |
ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
ATE124681T1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
DE69029884D1 (de) | 5-Methylisoxazol-4-carbonsäure-anilide und 2-Hydroxyethyliden-cyanoessigsäure-anilide zur Behandlung von Augenkrankheiten | |
ATE78395T1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
DE69008466D1 (de) | Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen. | |
DE3787954D1 (de) | Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen. | |
DE3866653D1 (de) | Zusammensetzung fuer die behandlung der epidermis. | |
DK275784D0 (da) | 6-(aminomethyl)penicillansyre-1,1-dioxid-estere, som er hydrolyserbare under fysiologiske betingelser, og aminobeskyttede 6-(aminomethyl)penicillansyre-forbindelser til anvendelse som mellemprodukter herfor | |
ATE37873T1 (de) | Verfahren zur herstellung optisch aktiver 1,4dihydropyridine. | |
ATE110720T1 (de) | Verfahren zur herstellung von 2-mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren ester. | |
ATE84784T1 (de) | Verfahren zur herstellung von 2-(2-chloroaethoxy)- benzosulfonamid. | |
ATE95061T1 (de) | Schmiermittelzubereitung zur behandlung von rheuma. | |
ATE58476T1 (de) | Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19920413 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20031031 |